Article
Highmark Takes on Outpatient Markups
Highmark, an insurer with its own health system, is challenging a growing and controversial billing practice that also happens to be a central part of some health system integration strategies.
Highmark, an insurer with its own health system, is challenging a growing and controversial billing practice that also happens to be a central part of some health system integration strategies.
Around August 2010, a lawsuit filed by Highmark contends, University of Pittsburgh Medical Centers hospitals and physician groups started charging “significantly higher prices for oncology drugs and related oncology services,” without any changes in treatment settings or outcomes.
Since then, Highmark alleges that it has been overcharged some $300 million. The cost of oncology drugs has tripled in the ensuing four years, the company argues, as office-based treatment has been billed as hospital outpatient services.
Read the full story: http://bit.ly/ZdC5ks
Source: Healthcare Payer News
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
